Skip to content

5-MeO-DMT: all studies

Page 100 of 110: studies 991 to 1,000 of 1,095, newest first. Back to the 5-MeO-DMT overview

Research

Modulation of oral movements by intranigral 5-hydroxytryptamine receptor agonists in the rat.

Pharmacology, Biochemistry, and Behavior October 1993 U Liminga, A E Johnson, P E Andrén et al.

Bilateral infusion of 5-hydroxytryptamine (5-HT) agonists into the substantia nigra pars reticulata (SNr) of awake rats was shown to influence oral behavior. The 5-HT1A agonist (R)-8-hydroxy-2-(di-propylamino)- tetralin (8-OH-DPAT) (1.3-13 nmol on each side) produced a dose-dependent depression of vacuous chewing movements (VCMs) that lasted about 20 min. The (R)-8-OH-DPAT-induced depression of...

5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices.

European Journal of Pharmacology September 22, 1992 J Yamazaki, H Fukuda, T Nagao et al. 38 citations

5-Methoxy-N,N-dimethyltryptamine (5-MeODMT) and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) facilitate motoneuron excitability through 5-HT1C/5-HT2 receptors in rats. Using spinal cord slices prepared from adult rats, we recorded unitary cell discharges, evoked by local stimulation of the adjacent site, extracellularly in the motor nuclei of the ventral horn. 5-MeODMT, DOI,...

Stimulatory and inhibitory effects of serotonergic hallucinogens on spinal mono- and polysynaptic reflex pathways in the rat.

Neuropharmacology July 1, 1992 J Yamazaki, H Ono, T Nagao 23 citations

The effects of two 5-HT-related hallucinogens on rat spinal mono- and polysynaptic reflex pathways in the rat were investigated. 5-Methoxy-N,N-dimethyltryptamine (5-MeODMT, 1 and 100 micrograms/kg, i.v.), an indolealkylamine agent, produced a dose-dependent decrease in the monosynaptic reflex, whereas 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI, 1-100 micrograms/kg), a phenylalkylamine...

Benzofuran bioisosteres of hallucinogenic tryptamines.

Journal of Medicinal Chemistry May 1, 1992 Z Tomaszewski, M P Johnson, X Huang et al.

The benzofuran analogues of the hallucinogens 5-methoxy-N,N-dimethyltryptamine and 5-methoxy-alpha-methyltryptamine were synthesized and evaluated for affinity at the serotonin 5-HT2 and 5-HT1A receptors in rat brain homogenate, labeled with [125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane ([125I]DOI) and [3H]-8-hydroxy-2-(N,N-di-n-propylamino)tetralin ([3H]-8-OH-DPAT), respectively. At the...

DOI: 10.1021/jm00089a017 (opens in new tab) Hippocampus Frontal lobe Animals Rats, inbred strains +12

Repeated administration of low doses of cocaine enhances the sensitivity of 5-HT2 receptor function.

Pharmacology, Biochemistry, and Behavior March 1, 1992 N A Darmani, B R Martin, Richard A Glennon 48 citations

The acute and chronic effects of cocaine were evaluated on the 5-hydroxytryptamine (5-HT)-receptor 5-HT2 mediated behavioral function, the head-twitch response (HTR), in mice. In a recent study, we reported that the (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI)-induced HTR was dose dependently reduced by cocaine via indirect stimulation of serotonergic 5-HT1A and adrenergic...

Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.

Biochemical Pharmacology June 1, 1991 A V Deliganis, P A Pierce, S J Peroutka

The interactions of the indolealkylamine N,N-dimethyltryptamine (DMT) with 5-hydroxytryptamine1A (5-HT1A) and 5-HT2 receptors in rat brain were analyzed using radioligand binding techniques and biochemical functional assays. The affinity of DMT for 5-HT1A sites labeled by [3H]-8-hydroxy-2-(di-n-propylamino)tetralin ([3H]-8-OH-DPAT) was decreased in the presence of 10(-4) M GTP, suggesting...

DOI: 10.1016/0006-2952(91)90178-8 (opens in new tab) Cerebral cortex Animals Rats N,N-Dimethyltryptamine +11

Human hallucinogenic drug research in the United States: a present-day case history and review of the process.

Journal of Psychoactive Drugs 1991 R J Strassman

Legitimate human research with hallucinogenic drugs, although of great theoretical and practical interest, involves daunting regulatory hurdles that have discouraged investigators from attempting such work. Using the example of the author's own application for and receipt of federal permission to administer N,N-dimethyltryptamine (DMT) to humans, this article reviews the application process,...

DOI: 10.1080/02791072.1991.10472572 (opens in new tab) Humans Hallucinogens Legislation, drug United states

Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.

Psychopharmacology 1991 Elaine Sanders‐bush, M Breeding

Behavioral, electrophysiological and biochemical evidence suggest that the 5HT2 receptor plays a role in the action of hallucinogenic agents. Considering the structural and functional similarities between the 5HT2 and 5HT1C receptors, we hypothesized that the 5HT1C receptor may also be an important site of action of hallucinogens. The present manuscript evaluates this hypothesis by examining...

Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies.

Biological Psychiatry November 15, 1990 B R Sitaram, W R Mcleod 29 citations

Although the psychotomimetic indolealkylamines N,N-dimethyltryptamine, 5-methoxy-N,N-dimethyltryptamine, and 5-hydroxy-N,N-dimethyltryptamine have been unequivocally identified in human body fluids, evidence relating their concentration to the presence of psychotic illness in humans remains controversial. A series of studies on the metabolism of the compounds in the rat have highlighted the...

Plants and mushrooms of abuse.

Emergency medicine clinics of North America August 1, 1990 D G Spoerke, A H Hall

The plants described earlier are only a few of those that can be misused. Most have effects similar to those of more popular synthetic drugs but can cause unpleasant side effects and unpredictable results. Identification of the offending botanic agent can be problematic. These plants are still used because most are legal to possess, and they do produce desired hallucinogenic and stimulant...

DOI: 10.1016/s0733-8627(20)30261-3 (opens in new tab) Full text (opens in new tab) Humans Basidiomycota Plants Substance-related disorders +1